Ask AI about DynaDes
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
0 Reviews
Italiano
No reviews
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About DynaDes
At DynaDes, they design pre-clinical drugs using innovative and proven, proprietary computational methods that account for protein dynamics and solvation effects. Combined with their in-house designed compound libraries and synthesis resources, their unique approach is remarkably efficient in generating novel, highly selective and potent drug candidates.
From the target definition up to clinical stage entry, DynaDes focuses on a streamlined approach to provide patented compounds addressing unmet medical needs.
Their current pipeline of products target the ATP-binding and allosteric sites of protein kinases, epigenetic targets and protein-protein interaction sites of proteins implicated in cancer. The particular selectivity of their compounds, coupled with their potency, solubility and toxicity profiles, renders them attractive for further development by their partner companies.
- Website
- dynades.com
